Trials / Conditions / Obstructive Lung Disease

Obstructive Lung Disease

10 registered clinical trials studyying Obstructive Lung Disease.

Status	Trial	Sponsor	Phase
Completed	Determinants of COVID-19 Pneumonia (MC-19) NCT04387799	Catholic University of the Sacred Heart	—
Completed	Prognostic Factors Keeping Track for COVID-19 Pneumonia NCT04324684	Catholic University of the Sacred Heart	—
Completed	Optimized Single-breath Helium Lung Volume in Obstructive Lung Disease NCT04919200	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Active Not Recruiting	Secondhand Smoke Respiratory Health Study NCT02797275	University of California, San Francisco	Phase 4
Completed	Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood NCT02820818	St. Justine's Hospital	—
Completed	Inhalation Therapy in Ambulant and Hospitalized Patient Using Available Film Sequences From the Internet NCT03087188	RWTH Aachen University	—
Withdrawn	Probiotic Use in Patients With Prior COPD Exacerbation NCT02185092	University of Oklahoma	N/A
Withdrawn	Airway Inflammation Among Workers in the Silicon Carbide Processing Industry NCT01337180	Sykehuset Telemark	—
Completed	Breathing and Bones Initiative NCT01161680	University of British Columbia	—
Unknown	Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study) NCT00920127	University of East Anglia	Phase 2 / Phase 3